cbdMD (NYSEAMERICAN:YCBD) Trading 11.9% Higher – What’s Next?

Shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) shot up 11.9% during mid-day trading on Monday . The company traded as high as $0.7930 and last traded at $0.7608. 1,176,922 shares changed hands during mid-day trading, an increase of 161% from the average session volume of 450,579 shares. The stock had previously closed at $0.68.

cbdMD Stock Performance

The firm’s 50 day moving average price is $0.83 and its 200 day moving average price is $0.92.

Institutional Investors Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC acquired a new position in cbdMD, Inc. (NYSEAMERICAN:YCBD) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned 0.49% of cbdMD at the end of the most recent reporting period. 7.18% of the stock is currently owned by hedge funds and other institutional investors.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.